SCHEMBL8293454

SCHEMBL8293454

CC(C)(C)OC(=O)NCCc1c(F)cccc1F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO2 P16083 1/20 0.51
▸ IDO1 P14902 2/20 0.47
▸ SCN9A Q15858 1/20 0.47
▸ GAA P10253 2/20 0.46
▸ LMNA P02545 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ NAMPT P43490 1/20 0.44
▸ MALT1 Q9UDY8 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ HTT P42858 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ CA1 P00915 2/20 0.43
▸ CA2 P00918 2/20 0.43
▸ POLB P06746 1/20 0.42
▸ BCHE P06276 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ GFER P55789 1/20 0.42
▸ CA12 O43570 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ CNR1 P21554 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23526333 0.90 NQO2 (0.46) NQO2IDO1SCN9AGAALMNA
SCHEMBL18685091 0.84 KDM4A (0.48) NQO2SCN9ANAMPTCA1POLB
SCHEMBL29845423 0.82 NQO2 (0.61) NQO2IDO1SCN9ALMNANAMPT
SCHEMBL18685355 0.79 KDM4A (0.44) NQO2SCN9ANAMPTCA1POLB
SCHEMBL25306120 0.79 KDM4A (0.44) NQO2SCN9ANAMPTCA1CA2
SCHEMBL5729170 0.78 CTSS (0.54) NQO2IDO1LMNANAMPTCA1
SCHEMBL3127618 0.78 KDM4A (0.43) NQO2IDO1SCN9ANAMPTCA1
SCHEMBL21987975 0.78 HDAC1 (0.46) NQO2SCN9ANAMPTCA1CA2
SCHEMBL29076001 0.78 POLB (0.44) SCN9ALMNANAMPTNPSR1POLB
SCHEMBL29473242 0.78 KDM4A (0.43) NQO2IDO1SCN9ANAMPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7449447-B2 Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus SCHERING CORPORATION (US) 2008-11-11 — — US disclosed
US-7449447-B2 Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus SCHERING CORPORATION (US) 2008-11-11 — — US disclosed
WO-2005021584-A2 NOVEL PEPTIDOMIMETIC NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS SCHERING CORPORATION (US) 2005-03-10 — — WO disclosed
Send feedback